JPH11228529A5 - - Google Patents

Info

Publication number
JPH11228529A5
JPH11228529A5 JP1998162707A JP16270798A JPH11228529A5 JP H11228529 A5 JPH11228529 A5 JP H11228529A5 JP 1998162707 A JP1998162707 A JP 1998162707A JP 16270798 A JP16270798 A JP 16270798A JP H11228529 A5 JPH11228529 A5 JP H11228529A5
Authority
JP
Japan
Prior art keywords
substituted
phenyl
alkyl
unsubstituted
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998162707A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11228529A (ja
JP4177484B2 (ja
Filing date
Publication date
Priority claimed from DE19719585A external-priority patent/DE19719585A1/de
Priority claimed from DE19719428A external-priority patent/DE19719428A1/de
Application filed filed Critical
Publication of JPH11228529A publication Critical patent/JPH11228529A/ja
Publication of JPH11228529A5 publication Critical patent/JPH11228529A5/ja
Application granted granted Critical
Publication of JP4177484B2 publication Critical patent/JP4177484B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP16270798A 1997-05-09 1998-05-08 置換されたジアミノカルボン酸 Expired - Fee Related JP4177484B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19719585A DE19719585A1 (de) 1997-05-09 1997-05-09 Substituierte Diaminocarbonsäuren
DE19719428:1 1997-05-12
DE19719585:7 1997-05-12
DE19719428A DE19719428A1 (de) 1997-05-12 1997-05-12 Substituierte Diaminocarbonsäuren

Publications (3)

Publication Number Publication Date
JPH11228529A JPH11228529A (ja) 1999-08-24
JPH11228529A5 true JPH11228529A5 (enExample) 2005-09-29
JP4177484B2 JP4177484B2 (ja) 2008-11-05

Family

ID=26036417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16270798A Expired - Fee Related JP4177484B2 (ja) 1997-05-09 1998-05-08 置換されたジアミノカルボン酸

Country Status (18)

Country Link
US (2) US6159995A (enExample)
EP (1) EP0877019B1 (enExample)
JP (1) JP4177484B2 (enExample)
KR (1) KR19980086893A (enExample)
AR (1) AR012675A1 (enExample)
AT (1) ATE210639T1 (enExample)
AU (1) AU736700B2 (enExample)
BR (1) BR9801604A (enExample)
CA (1) CA2237052A1 (enExample)
CZ (1) CZ143998A3 (enExample)
DE (1) DE59802394D1 (enExample)
DK (1) DK0877019T3 (enExample)
ES (1) ES2165640T3 (enExample)
HU (1) HUP9801045A3 (enExample)
ID (1) ID20809A (enExample)
PL (1) PL326218A1 (enExample)
PT (1) PT877019E (enExample)
TR (1) TR199800818A3 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren
US6410580B1 (en) 1998-02-04 2002-06-25 Novartis Ag Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
CN1195735C (zh) * 1998-02-04 2005-04-06 诺瓦提斯公司 抑制使基质退化的金属蛋白酶的磺酰氨基衍生物
CN1304402A (zh) * 1998-04-03 2001-07-18 三共株式会社 磺酰胺衍生物
ATE227295T1 (de) 1998-07-16 2002-11-15 Aventis Pharma Gmbh Phosphin- und phosphonsäurederivate als arzneimittel
EP1165530A2 (en) 1999-03-03 2002-01-02 The Procter & Gamble Company Dihetero-substituted metalloprotease inhibitors
IL145089A0 (en) * 1999-03-03 2002-06-30 Procter & Gamble Alkenyl-and alkynyl-containing metalloprotease inhibitors
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
US20040235896A1 (en) * 2001-03-14 2004-11-25 Fujimoto Roger Aki Certain azacycloalkyl substituted acetic acid derivatives
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
GB0412553D0 (en) * 2004-06-04 2004-07-07 Univ Aberdeen Therapeutic agents for the treatment of bone conditions
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
US7388008B2 (en) * 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
ES2539527T3 (es) * 2005-04-27 2015-07-01 Taimed Biologics, Inc. Método para mejorar la farmacocinética de los inhibidores de las proteasas y de los precursores de los inhibidores de las proteasas
JP2009517412A (ja) * 2005-11-30 2009-04-30 アンブリリア バイオファーマ インコーポレイテッド アスパルチルプロテアーゼ阻害物質のリジンベースのプロドラッグ及びその調製方法
US8410300B2 (en) 2006-09-21 2013-04-02 Taimed Biologics, Inc. Protease inhibitors
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
US8093265B2 (en) 2007-03-09 2012-01-10 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
GB0705400D0 (en) 2007-03-21 2007-05-02 Univ Aberdeen Therapeutic compounds andm their use
GB0817208D0 (en) 2008-09-19 2008-10-29 Pimco 2664 Ltd Therapeutic apsap compounds and their use
GB0817207D0 (en) 2008-09-19 2008-10-29 Pimco 2664 Ltd therapeutic apsac compounds and their use
GB201311361D0 (en) 2013-06-26 2013-08-14 Pimco 2664 Ltd Compounds and their therapeutic use
CA2970578C (en) 2014-12-17 2024-01-02 Pimco 2664 Limited N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use
EP3560917B1 (en) * 2016-12-22 2023-12-20 Guangzhou Chinaray Optoelectronic Materials Ltd. Polymer containing furan crosslinking group and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2764262B2 (ja) * 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (enExample) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5506242A (en) * 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US6022898A (en) * 1994-06-22 2000-02-08 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
DK0821671T3 (da) * 1995-04-20 2001-04-23 Pfizer Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer
KR980009238A (ko) * 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
US5977141A (en) * 1995-11-17 1999-11-02 Warner-Lambert Company Sulfonamide inhibitors of matrix metalloproteinases
WO1997045402A1 (fr) 1996-05-24 1997-12-04 Ono Pharmaceutical Co., Ltd. Derives de phenylsulfonamide

Similar Documents

Publication Publication Date Title
JPH11228529A5 (enExample)
JPH1160551A5 (enExample)
CA2457054A1 (en) Activator of peroxisome proliferator-activated receptor .delta.
JPH10316662A5 (enExample)
YU47066B (sh) Postupak za dobijanje derivata tiazolidin-2,4-diona
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
MXPA03010584A (es) Derivados de tiazol u oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas.
JP2010514786A5 (enExample)
JP2004525117A5 (enExample)
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
SE7607201L (sv) Forfarande for framstellning av nya tienopyridinderivat
NZ508066A (en) Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
ATE478885T1 (de) Pharmazeutische dopamin-glykokonjugat- zusammensetzungen und verfahren zu deren herstellung
RU94034117A (ru) Производные азола, способы их получения и антигрибковое средство
SE0201937D0 (sv) Therapeutic agents
KR890014534A (ko) 혈당 감소제로서 티아졸리딘디온 유도체
JP2005538944A5 (enExample)
JP2006517201A5 (enExample)
JP2018507273A5 (enExample)
DE69828516D1 (de) (hetero)aryl-sulfonamid derivate, deren herstellung und deren verwenddung als faktor xa inhibitoren
MXPA03011032A (es) Activadores de derivados de oxazol/tiazol del receptor hppar-alfa.
KR930700411A (ko) 시클로헥산올 유도체의 질산 에스테르
EA200200041A1 (ru) Новые четвертичные соединения аммония, способ их получения и фармацевтическое применение
EA200101050A1 (ru) Замещенные бензолактамные соединения